Covaris, LLC, a biotechnology company specializing in advanced tools for genomics, proteomics, and drug discovery, recently experienced a data breach that may have exposed sensitive personal information.
The breach was disclosed to the Massachusetts Attorney General's office on December 27, 2024. While the exact number of affected individuals has not been disclosed, Covaris has confirmed that the following types of consumer information may have been exposed:
The breach occurred when an unauthorized actor gained access to a dataset containing this information. Covaris has stated that there is no evidence of misuse of the data at this time, but the exposure of such sensitive information poses significant risks, including identity theft and financial fraud.
For more details, you can view the Massachusetts Attorney General's disclosure.
In response to the breach, Covaris has taken several steps to address the situation and protect affected individuals. The company has conducted a thorough investigation, assessed the security of its network, and notified potentially impacted individuals. Covaris has also reported the incident to relevant regulatory authorities.
To support affected individuals, Covaris is offering 24 months of complimentary credit monitoring and identity protection services through Experian IdentityWorks. These services include identity restoration assistance, credit monitoring, and up to $1 million in identity theft insurance. Affected individuals are encouraged to enroll in these services by March 31, 2025. Instructions for enrollment, including an activation code, are provided in the notice sent to impacted individuals.
If you believe you may have been affected by the Covaris data breach, it is crucial to take immediate action to protect your personal information: